SJS Investment Consulting »

Fennec Pharmaceuticals shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2026-06-30 $139 13 10.77

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultr Fix Inc Etf (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Eli Lilly & Co. (LLY)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Apple (AAPL)
American Centy Etf Tr Us Eqt Etf (AVUS)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Hormel Foods Corporation (HRL)
American Centy Etf Tr Avan Tota Eq Etf (AVTM)
Dimensional Etf Trust Global Real Est (DFGR)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Us Sustainabilty (DFSU)

View all positions for SJS Investment Consulting

Top funds holding Fennec Pharmaceuticals

Rosalind Advisors
AIGH Capital Management
Solas Capital Management
BlackRock
AWM Investment Company
Vanguard Capital Management
Prospect Capital Advisors
Geode Capital Management
State Street Corporation
Jane Street
Potomac Capital Management
Morgan Stanley
Vanguard Portfolio Management
Northern Trust
Marshall Wace

View all funds holding Fennec Pharmaceuticals